We believe that the progressive decline in TB incidence over the past seven years is testament to the success of our TB monitoring and early treatment programmes, which include the introduction of new technologies as they emerge (such as the routine Gene Xpert for rapid diagnostic testing), on-going dust control measures, our HIV testing and counselling programmes, and antiretroviral therapy.